121 related articles for article (PubMed ID: 4299216)
21. Acetylcholine-induced stimulation of catecholamine recovery in denervated rat adrenals after reserpine-induced depletion.
Patrick RL; Kirshner N
Mol Pharmacol; 1971 Jul; 7(4):389-96. PubMed ID: 4398814
[No Abstract] [Full Text] [Related]
22. Decrease of some metabolic and physiologic effects of diazoxide by propranolol in rat.
Johansson SR; Andersson RG
Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):190-3. PubMed ID: 6264332
[TBL] [Abstract][Full Text] [Related]
23. Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent.
Bressler R; Vargas-Cord M; Lebovitz HE
Diabetes; 1968 Oct; 17(10):617-24. PubMed ID: 4878653
[No Abstract] [Full Text] [Related]
24. [Role of catecholamines in hypoxia and hyperglycemia induced by injection of cystamine].
Duyckaerts C
Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):400-4. PubMed ID: 4397370
[No Abstract] [Full Text] [Related]
25. A morphological study on the mechanism of diazoxide-hyperglycemia (clinical and experimental investigation).
Yoshinaga T
Endokrinologie; 1969; 54(5):410-22. PubMed ID: 4188182
[No Abstract] [Full Text] [Related]
26. Phenothiazine-induced hyperglycemia: relation to CNS and adrenal effects.
Proakis AG; Mennear JH; Miya TS; Borowitz JL
Proc Soc Exp Biol Med; 1971 Sep; 137(4):1385-8. PubMed ID: 5138468
[No Abstract] [Full Text] [Related]
27. Diazoxide: a review of its pharmacological properties and therapeutic use in hypertensive crises.
Drugs; 1971; 2(2):78-137. PubMed ID: 4336104
[No Abstract] [Full Text] [Related]
28. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Loubatiéres A; Mariani MM
Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
[No Abstract] [Full Text] [Related]
29. [Present-day concepts of the mechanism of the glucose induction of insulin secretion].
Genes SG; Zhurova MV; Poltorak VV
Probl Endokrinol (Mosk); 1980; 26(5):73-81. PubMed ID: 6253986
[No Abstract] [Full Text] [Related]
30. [Diabetogenic activity of diazoxide].
Zahnd GR; Luyckx A
Helv Med Acta Suppl; 1966 May; 46():163. PubMed ID: 5286273
[No Abstract] [Full Text] [Related]
31. Adrenergic receptors for metabolic responses in the liver.
Hornbrook KR
Fed Proc; 1970; 29(4):1381-5. PubMed ID: 4318931
[No Abstract] [Full Text] [Related]
32. Insulin secretion studied in the perfused rat pancreas. II. Effect of glucose, glucagon, 3'5' adenosine monophosphate, theophylline, imidazole and phenoxybenzamine; their interaction with diazoxide.
Basabe JC; Lopez NL; Viktora JK; Wolff FW
Diabetes; 1971 Jul; 20(7):457-66. PubMed ID: 4397560
[No Abstract] [Full Text] [Related]
33. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
Leahy JL; Bumbalo LM; Chen C
Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
[TBL] [Abstract][Full Text] [Related]
34. Drug control of hyperglycemia and inhibition of insulin secretion due to centrally administered 2-deoxy-D-glucose.
Müller EE; Frohman LA; Cocchi D
Am J Physiol; 1973 May; 224(5):1210-7. PubMed ID: 4700641
[No Abstract] [Full Text] [Related]
35. The hyperglycemic and antidiuretic activity of a phthalimidine analogue: 1-oxo-3-(4'-chlorophenyl)-3-hydroxyisoindoline (C3-176).
Wales JK; Bradley P; Viktora J; Wolff FW
Proc Soc Exp Biol Med; 1968 Jun; 128(2):581-7. PubMed ID: 5663278
[No Abstract] [Full Text] [Related]
36. [Mechanism of action of a hyperglycemic sulfonamide, Diazoxide].
Loubatières A; Mariani MM; Alric R; Ribes G; De Malbosc H; Chapal J
Ann Endocrinol (Paris); 1966; 27(6):787-94. PubMed ID: 5339929
[No Abstract] [Full Text] [Related]
37. A study of the mechanism of ethacrynic acid induced hyperglycemia.
Lebacq E; Marcq M
Rev Fr Etud Clin Biol; 1967 Feb; 12(2):160-2. PubMed ID: 6058678
[No Abstract] [Full Text] [Related]
38. Nonketoacidotic hyperglycemia and coma during intravenous diazoxide therapy in uremia.
Charles MA; Danforth E
Diabetes; 1971 Jul; 20(7):501-3. PubMed ID: 5556285
[No Abstract] [Full Text] [Related]
39. [Oral antidiabetics. Dose, plasma concentration and effect].
Ariëns EJ
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():143-76. PubMed ID: 4392071
[No Abstract] [Full Text] [Related]
40. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
Loubatières A
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
